SAMRAT PHARMACHEM
Back to Cashflow Statement
|
SAMRAT PHARMACHEM Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-11 Cr | ₹9.60 Cr | ₹-1.95 Cr | ₹-1.89 Cr | ₹2.00 Cr |
What is the latest Cash Flow from Financing Activities ratio of SAMRAT PHARMACHEM ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-11 Cr |
Mar2023 | ₹9.60 Cr |
Mar2022 | ₹-1.95 Cr |
Mar2021 | ₹-1.89 Cr |
Mar2020 | ₹2.00 Cr |
How is Cash Flow from Financing Activities of SAMRAT PHARMACHEM Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-11 Cr | Negative | |
Mar2023 | ₹9.60 Cr | Positive | |
Mar2022 | ₹-1.95 Cr | Negative | |
Mar2021 | ₹-1.89 Cr | Negative | |
Mar2020 | ₹2.00 Cr | - |
Compare Cash Flow from Financing Activities of peers of SAMRAT PHARMACHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAMRAT PHARMACHEM | ₹114.7 Cr | -0.4% | 8.4% | 3.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
SAMRAT PHARMACHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAMRAT PHARMACHEM | -0.4% |
8.4% |
3.8% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses